IGC Pharma, Inc. Annual Earnings Per Share, Diluted in USD/shares from 2010 to 2016

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
IGC Pharma, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from 2010 to 2016.
  • IGC Pharma, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2024 was -0.02 USD/shares, a 60% increase year-over-year.
  • IGC Pharma, Inc. annual Earnings Per Share, Diluted for 2016 was -0.07 USD/shares, a 58.8% increase from 2015.
  • IGC Pharma, Inc. annual Earnings Per Share, Diluted for 2015 was -0.17 USD/shares, a 45.2% increase from 2014.
  • IGC Pharma, Inc. annual Earnings Per Share, Diluted for 2014 was -0.31 USD/shares, a 16.2% increase from 2013.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2016 $0 +$0.10 +58.8% Apr 1, 2016 Mar 31, 2017 10-K 2017-07-14
2015 $0 +$0.14 +45.2% Apr 1, 2015 Mar 31, 2016 10-K 2017-07-14
2014 $0 +$0.06 +16.2% Apr 1, 2014 Mar 31, 2015 10-K 2016-07-14
2013 $0 $0 -15.6% Apr 1, 2013 Mar 31, 2014 10-K 2015-07-14
2012 $0 +$2.34 +88% Apr 1, 2012 Mar 31, 2013 10-K 2014-07-15
2011 -$3 -$1 -98.5% Apr 1, 2011 Mar 31, 2012 10-K/A 2014-07-15
2010 -$1 Apr 1, 2010 Mar 31, 2011 10-K 2012-07-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.